Deborah M. Autor is Director at Amneal Pharmaceuticals, Inc. (AMRX). They have made 3 open-market trades across 1 company since 2024, most recently 2026-08-18.
CIK 0001884671
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AMRX | 93,660 | $1.8M |
| HIMS | 48,961 | $1.4M |
| Total | $3.2M |
Shares reported on the most recent Form 4, priced at the 2026-08-20 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HIMS | SELL · 10b5-1 | 2026-08-18 | 2026-08-20 | $27.85 | $467K | -10.9% | -8.2% | — |
| AMRX | SELL | 2026-05-11 | 2026-05-12 | $12.94 | $451K | -0.6% | +30.8% | +43.1% |
| HIMS | SELL · 10b5-1 | 2025-12-17 | 2025-12-18 | $36.71 | $518K | -7.1% | -12.9% | -33.8% |
| AMRX | SELL | 2024-11-21 | 2024-11-25 | $8.35 | $668K | +1.6% | -5.6% | -0.2% |
| AMRX | SELL | 2024-05-16 | 2024-05-20 | $6.74 | $512K | +0.1% | +1.2% | +22.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.